dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Borrero-Palacios, Áurea |
dc.contributor.author | Cebrián, A |
dc.contributor.author | Gómez Del Pulgar, MT |
dc.contributor.author | García, P |
dc.contributor.author | Elez Fernandez, Mª Elena |
dc.contributor.author | Garcia-Carbonero, Rocio |
dc.contributor.author | Aranda Aguilar, Enrique |
dc.date.accessioned | 2019-04-01T07:17:42Z |
dc.date.available | 2019-04-01T07:17:42Z |
dc.date.issued | 2019-02-22 |
dc.identifier.citation | Borrero-Palacios A, Cebrián A, Gómez del Pulgar MT, García-Carbonero R, García P, Aranda E, et al. Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer. Sci Rep. 2019;9(1):2589. |
dc.identifier.issn | 2045-2322 |
dc.identifier.uri | https://hdl.handle.net/11351/3884 |
dc.description | Cetuximab; Càncer colorectal amb metàstasi; Gens KIR |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | Scientific Reports;9(1) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Còlon - Càncer |
dc.subject | Mutació (Biologia) |
dc.subject | Cetuximab |
dc.subject.mesh | Colorectal Neoplasms |
dc.subject.mesh | Cetuximab |
dc.subject.mesh | Receptors, KIR |
dc.subject.mesh | /genetics |
dc.title | Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41598-019-39291-2 |
dc.subject.decs | neoplasias colorrectales |
dc.subject.decs | cetuximab |
dc.subject.decs | receptores KIR |
dc.subject.decs | /genética |
dc.relation.publishversion | https://www.nature.com/articles/s41598-019-39291-2 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Borrero-Palacios A, Cebrián A, Gómez Del Pulgar MT] Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain. [García-Carbonero R] Medical Oncology Department, Hospital Virgen del Rocío, Sevilla, Spain. [García P] Medical Oncology Department, Hospital Gral. Univ. Gregorio Marañón, Madrid, Spain. [Aranda E] Medical Oncology Department, Hospital Universitario Reina Sofía, Córdoba, Spain. [Elez E] Servei d’Oncologia Mèdica, Hospital Universitari Vall d'Hebron, Barcelona, Spain. |
dc.identifier.pmid | 30796344 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |